This week, the parents of Luke Tyler, the Washington State University (WSU) freshman who was found dead in his dorm room on January 22, 2023, filed a wrongful death lawsuit in the King County Superior ...

Hims reports that 65% of men misunderstand low testosterone, with common misconceptions hindering awareness of men's sexual ...

Between 30 million and 50 million men in the US have erectile dysfunction, including a staggering 70% of men over 70.

Direct-to-consumer (DTC) telehealth companies remove barriers to care, but questions remain regarding patient safety and proper information.

Telehealth company Hims & Hers Health Inc. said late Monday it is in "active discussions" with Denmark's Novo Nordisk A/S to make Wegovy available on its platform.

Hims does not yet have an agreement with Novo and there’s “a possibility that no definitive agreement may ever be executed ...

The legendary NBA star is part of NBC’s coverage. NBC announced Michael Jordan's new weekly segment, "Insights to Excellence," during NBA broadcasts. Jordan aims to "pay it forward" by sharing ...

What To Know: While Hims & Hers doesn’t manufacture the GLP-1 drugs, a class of medications that help manage Type 2 diabetes and obesity, like Eli Lilly’s Zepbound and Novo Nordisk’s Ozempic, it sells ...

Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...

Hims & Hers (NYSE:HIMS) has lost its charm amongst investors. The reason for this loss of interest is straightforward. Its outlook points towards decelerating revenue growth rates. As a result, growth ...

Hims & Hers is driving growth through holistic treatment plans, strategic pharma partnerships, and expanded prescription offerings to boost revenue per subscriber. HIMS' recent partnership with Marius ...